Pfizer Canada has contributed $800,000 to MaRS Innovation to support new ideas or technologies in health sciences research in areas of therapeutics, diagnostic and treatment tools, and manufacturing technologies. The MaRS Innovation – Pfizer Translational Research Fund will be managed by MaRS Innovation. Priority projects are in cardiovascular disease, inflammation, immunology, rare diseases, vaccines, and…
Topic: life sciences
Last month, Québec tabled its 2018 budget, which includes more than $1 billion for research, innovation and economic growth, reflecting several recommendations made by the Advisory Council on the Economy and Innovation.
With elections just around the corner, Ontario Liberals released earlier than usual its 2018 budget, which includes at least $1.5 billion for R&D and innovation. The $158.5-billion spending plan focuses largely on enhanced social, education and healthcare initiatives but also commits millions to businesses as well as R&D, innovation and competitiveness.
Ontario has announced a life sciences venture capital initiative to provide provincial firms with much-needed capital to grow their business. The Ontario Capital Growth Corporation (OCGC), the agency managing the province’s VC interests, is seeking fund managers who can leverage the province’s $50-million investment.